2372-3541 Screening compound: 2-(2-{4-[(2-carboxy-4-hydroxyphenyl)carbamoyl]phenyl}-1,3-dioxo-2,3-dihydro-1H-isoindole-5-amido)-5-hydroxybenzoic acid

2372-3541 Screening compound: 2-(2-{4-[(2-carboxy-4-hydroxyphenyl)carbamoyl]phenyl}-1,3-dioxo-2,3-dihydro-1H-isoindole-5-amido)-5-hydroxybenzoic acid
2372-3541 Screening compound: 2-(2-{4-[(2-carboxy-4-hydroxyphenyl)carbamoyl]phenyl}-1,3-dioxo-2,3-dihydro-1H-isoindole-5-amido)-5-hydroxybenzoic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound 2372-3541
2-(2-{4-[(2-carboxy-4-hydroxyphenyl)carbamoyl]phenyl}-1,3-dioxo-2,3-dihydro-1H-isoindole-5-amido)-5-hydroxybenzoic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2372-3541

Molecular Formula

C30H19N3O10 (C30 H19 N3 O10)

Compound Name

2-(2-{4-[(2-carboxy-4-hydroxyphenyl)carbamoyl]phenyl}-1,3-dioxo-2,3-dihydro-1H-isoindole-5-amido)-5-hydroxybenzoic acid

IUPAC name

2-(2-{4-[(2-carboxy-4-hydroxyphenyl)carbamoyl]phenyl}-13-dioxo-23-dihydro-1H-isoindole-5-amido)-5-hydroxybenzoic acid

SMILES

OC(c(cc(cc1)O)c1NC(c(cc1)ccc1N(C(c(cc1)c2cc1C(Nc(ccc(O)c1)c1C(O)=O)=O)=O)C2=O)=O)=O

InChI

InChI=1S/C30H19N3O10/c34-17-6-9-23(21(12-17)29(40)41)31-25(36)14-1-4-16(5-2-14)33-27(38)19-8-3-15(11-20(19)28(33)39)26(37)32-24-10-7-18(35)13-22(24)30(42)43/h1-13,34-35H,(H,31,36)(H,32,37)(H,40,41)(H,42,43)

InChI Key

QVSKSIBYVGADEH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01003850

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

581.5

Hydrogen Bond Acceptors Count

16.00

Hydrogen Bond Donors Count

6.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

13

Partition Coefficient, logP

3.322

Distribution Coefficient, logD

-1.233

Water Solubility, LogSw

-3.59

Polar Surface Area

165.717

Acid Dissociation Constant (pKa)

2.85

Base Dissociation Constant (pKb)

-2.51

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

0.00

2372-3541 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

PLpro Library (6343 compounds)

Antibacterial Compounds Library (13827 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Infections
  • Immune system
  • animal
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with 2372-3541 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2372-3541?
Check Price and Availability of 2372-3541, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2372-3541 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2372-3541
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2372-3541
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2372-3541 available by request